• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA-381通过抑制YY1抑制上皮性卵巢癌的恶性程度。

MiR-381 inhibits epithelial ovarian cancer malignancy via YY1 suppression.

作者信息

Xia Bairong, Li Huiyan, Yang Shanshan, Liu Tianbo, Lou Ge

机构信息

Department of Gynecology, the Affiliated Tumor Hospital, Harbin Medical University, 150 Haping Rd, Nangang, Harbin, Heilongjiang, 150020, China.

Department of Nursing, the Affiliated Tumor Hospital, Harbin Medical University, Harbin, 150020, China.

出版信息

Tumour Biol. 2016 Jul;37(7):9157-67. doi: 10.1007/s13277-016-4805-8. Epub 2016 Jan 14.

DOI:10.1007/s13277-016-4805-8
PMID:26768613
Abstract

Epithelial ovarian cancer (EOC) is a common type of gynecologic cancer, which accounts for the majority of deaths among all gynecologic malignant tumors in developed countries. A series of recent studies suggested that miR-381 might play important roles in the development of various cancer types. However, the biological function of miR-381 in EOC remains to be investigated. We examined the levels of miR-381 expression in EOC tissues and cell lines. We identified miR-381 target genes by bioinformatic prediction. We also characterized the phenotype regarding cell proliferation, cell migration, and cell invasion in EOC cells lines with altered expression levels of both miR-381 and its target gene, YY1. The expression levels of miR-381 were downregulated in EOC tissues and cell lines. Overexpression of miR-381 significantly inhibited EOC cell proliferation, migration, and invasion. Restoration of YY1 expression partially reversed the phenotype induced by miR-381 overexpression. Knockdown of miR-381 target gene, YY1, mimicked the phenotype induced by miR-381 overexpression. MiR-381 regulated EOC cell through miR-381/YY1/p53 and miR-381/YY1/Wnt signaling axis. We concluded that miR-381 inhibited EOC cell proliferation, migration, and invasion, at least in part, via suppressing YY1 expression.

摘要

上皮性卵巢癌(EOC)是一种常见的妇科癌症,在发达国家,它在所有妇科恶性肿瘤导致的死亡中占大多数。最近一系列研究表明,miR-381可能在多种癌症类型的发生发展中发挥重要作用。然而,miR-381在EOC中的生物学功能仍有待研究。我们检测了EOC组织和细胞系中miR-381的表达水平。通过生物信息学预测鉴定了miR-381的靶基因。我们还对miR-381及其靶基因YY1表达水平改变的EOC细胞系中的细胞增殖、细胞迁移和细胞侵袭的表型进行了表征。miR-381在EOC组织和细胞系中的表达水平下调。miR-381的过表达显著抑制了EOC细胞的增殖、迁移和侵袭。YY1表达的恢复部分逆转了miR-381过表达诱导的表型。敲低miR-381的靶基因YY1模拟了miR-381过表达诱导的表型。miR-381通过miR-381/YY1/p53和miR-381/YY1/Wnt信号轴调节EOC细胞。我们得出结论,miR-381至少部分通过抑制YY1的表达来抑制EOC细胞的增殖、迁移和侵袭。

相似文献

1
MiR-381 inhibits epithelial ovarian cancer malignancy via YY1 suppression.微小RNA-381通过抑制YY1抑制上皮性卵巢癌的恶性程度。
Tumour Biol. 2016 Jul;37(7):9157-67. doi: 10.1007/s13277-016-4805-8. Epub 2016 Jan 14.
2
miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6.微小RNA-211通过靶向细胞周期蛋白D1和细胞周期蛋白依赖性激酶6抑制上皮性卵巢癌的增殖和细胞周期进程。
Mol Cancer. 2015 Mar 11;14:57. doi: 10.1186/s12943-015-0322-4.
3
LncRNA HOXD-AS1 promotes epithelial ovarian cancer cells proliferation and invasion by targeting miR-133a-3p and activating Wnt/β-catenin signaling pathway.长链非编码 RNA HOXD-AS1 通过靶向 miR-133a-3p 并激活 Wnt/β-catenin 信号通路促进卵巢癌细胞的增殖和侵袭。
Biomed Pharmacother. 2017 Dec;96:1216-1221. doi: 10.1016/j.biopha.2017.11.096. Epub 2017 Nov 26.
4
MicroRNA-145 targets TRIM2 and exerts tumor-suppressing functions in epithelial ovarian cancer.微小RNA-145靶向TRIM2并在上皮性卵巢癌中发挥肿瘤抑制功能。
Gynecol Oncol. 2015 Dec;139(3):513-9. doi: 10.1016/j.ygyno.2015.10.008. Epub 2015 Oct 16.
5
S100A7 Regulates Ovarian Cancer Cell Metastasis and Chemoresistance Through MAPK Signaling and Is Targeted by miR-330-5p.S100A7 通过 MAPK 信号调节卵巢癌细胞转移和化疗耐药性,并且受 miR-330-5p 靶向调控。
DNA Cell Biol. 2018 May;37(5):491-500. doi: 10.1089/dna.2017.3953. Epub 2018 Feb 27.
6
MicroRNA-130b functions as a tumor suppressor by regulating RUNX3 in epithelial ovarian cancer.微小RNA-130b通过调控上皮性卵巢癌中的RUNX3发挥肿瘤抑制作用。
Gene. 2016 Jul 15;586(1):48-55. doi: 10.1016/j.gene.2016.04.001. Epub 2016 Apr 2.
7
MiR-135a functions as a tumor suppressor in epithelial ovarian cancer and regulates HOXA10 expression.miR-135a 在卵巢上皮性癌中作为肿瘤抑制因子发挥作用,并调节 HOXA10 的表达。
Cell Signal. 2014 Jul;26(7):1420-6. doi: 10.1016/j.cellsig.2014.03.002. Epub 2014 Mar 6.
8
MicroRNA-520g promotes epithelial ovarian cancer progression and chemoresistance via DAPK2 repression.微小RNA-520g通过抑制DAPK2促进上皮性卵巢癌进展和化疗耐药。
Oncotarget. 2016 May 3;7(18):26516-34. doi: 10.18632/oncotarget.8530.
9
MicroRNA-127-3p acts as a tumor suppressor in epithelial ovarian cancer by regulating the BAG5 gene.微小RNA-127-3p通过调控BAG5基因在上皮性卵巢癌中发挥抑癌作用。
Oncol Rep. 2016 Nov;36(5):2563-2570. doi: 10.3892/or.2016.5055. Epub 2016 Aug 29.
10
MiR-26b/KPNA2 axis inhibits epithelial ovarian carcinoma proliferation and metastasis through downregulating OCT4.微小RNA-26b/核转运蛋白α2轴通过下调八聚体结合转录因子4抑制上皮性卵巢癌的增殖和转移。
Oncotarget. 2015 Sep 15;6(27):23793-806. doi: 10.18632/oncotarget.4363.

引用本文的文献

1
Role of DNA methylation and non‑coding RNAs expression in pathogenesis, detection, prognosis, and therapy‑resistant ovarian carcinoma (Review).DNA甲基化和非编码RNA表达在卵巢癌发病机制、检测、预后及治疗抵抗中的作用(综述)
Mol Med Rep. 2025 Jun;31(6). doi: 10.3892/mmr.2025.13509. Epub 2025 Apr 4.
2
Progranulin modulates the progression of non-small cell lung cancer through lncRNA H19.颗粒蛋白前体通过长链非编码RNA H19调节非小细胞肺癌的进展。
Am J Transl Res. 2023 Jul 15;15(7):4887-4901. eCollection 2023.
3
Targeting Transcription Factor YY1 for Cancer Treatment: Current Strategies and Future Directions.

本文引用的文献

1
[MiRNA-381 inhibits the invasion of renal carcinoma and 
the underlying mechanisms].[微小RNA-381抑制肾癌侵袭及其潜在机制]
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2015 Oct;40(10):1053-9. doi: 10.11817/j.issn.1672-7347.2015.10.001.
2
Targeting of RUNX3 by miR-130a and miR-495 cooperatively increases cell proliferation and tumor angiogenesis in gastric cancer cells.miR-130a和miR-495协同靶向RUNX3可增加胃癌细胞的增殖和肿瘤血管生成。
Oncotarget. 2015 Oct 20;6(32):33269-78. doi: 10.18632/oncotarget.5037.
3
Down-regulation of MicroRNA-381 promotes cell proliferation and invasion in colon cancer through up-regulation of LRH-1.
靶向转录因子YY1用于癌症治疗:当前策略与未来方向
Cancers (Basel). 2023 Jul 5;15(13):3506. doi: 10.3390/cancers15133506.
4
circSOX4 Enhances Hepatocellular Carcinoma Progression via miR-218-5p/YY1 Signaling.环状 RNA Sox4 通过 miR-218-5p/YY1 信号增强肝癌进展。
Biomed Res Int. 2023 Apr 25;2023:3370440. doi: 10.1155/2023/3370440. eCollection 2023.
5
The Emerging Role of Chromatin Remodeling Complexes in Ovarian Cancer.染色质重塑复合物在卵巢癌中的新兴作用。
Int J Mol Sci. 2022 Nov 8;23(22):13670. doi: 10.3390/ijms232213670.
6
Deregulated miRNA clusters in ovarian cancer: Imperative implications in personalized medicine.卵巢癌中失调的miRNA簇:对个性化医疗的重要意义。
Genes Dis. 2022 Mar 1;9(6):1443-1465. doi: 10.1016/j.gendis.2021.12.026. eCollection 2022 Nov.
7
miR-381 Inhibits Proliferation and Invasion of Non-Small-Cell Cancer Cells by Targeting USP39.miR-381 通过靶向 USP39 抑制非小细胞癌细胞的增殖和侵袭。
Dis Markers. 2022 Aug 21;2022:2195393. doi: 10.1155/2022/2195393. eCollection 2022.
8
Exploring the Study of miR-1301 Inhibiting the Proliferation and Migration of Squamous Cell Carcinoma YD-38 Cells through PI3K/AKT Pathway under Deep Learning Medical Images.深度学习医学图像下 miR-1301 通过 PI3K/AKT 通路抑制鳞状细胞癌细胞 YD-38 增殖和迁移的研究。
Comput Intell Neurosci. 2022 Feb 10;2022:5865640. doi: 10.1155/2022/5865640. eCollection 2022.
9
CPNE1 is a potential prognostic biomarker, associated with immune infiltrates and promotes progression of hepatocellular carcinoma.CPNE1是一种潜在的预后生物标志物,与免疫浸润相关,并促进肝细胞癌的进展。
Cancer Cell Int. 2022 Feb 9;22(1):67. doi: 10.1186/s12935-022-02485-2.
10
MicroRNA-381 in human cancer: Its involvement in tumour biology and clinical applications potential.微小 RNA-381 在人类癌症中的作用:其在肿瘤生物学和临床应用潜力中的参与。
J Cell Mol Med. 2022 Feb;26(4):977-989. doi: 10.1111/jcmm.17161. Epub 2022 Jan 11.
下调 microRNA-381 通过上调 LRH-1 促进结肠癌细胞增殖和侵袭。
Biomed Pharmacother. 2015 Oct;75:137-41. doi: 10.1016/j.biopha.2015.07.020. Epub 2015 Aug 28.
4
The PTTG1-targeting miRNAs miR-329, miR-300, miR-381, and miR-655 inhibit pituitary tumor cell tumorigenesis and are involved in a p53/PTTG1 regulation feedback loop.靶向PTTG1的微小RNA miR-329、miR-300、miR-381和miR-655可抑制垂体肿瘤细胞的肿瘤发生,并参与p53/PTTG1调节反馈回路。
Oncotarget. 2015 Oct 6;6(30):29413-27. doi: 10.18632/oncotarget.5003.
5
miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6.微小RNA-211通过靶向细胞周期蛋白D1和细胞周期蛋白依赖性激酶6抑制上皮性卵巢癌的增殖和细胞周期进程。
Mol Cancer. 2015 Mar 11;14:57. doi: 10.1186/s12943-015-0322-4.
6
MicroRNA-449a inhibits proliferation and induces apoptosis by directly repressing E2F3 in gastric cancer.微小RNA-449a通过直接抑制E2F3抑制胃癌细胞增殖并诱导其凋亡。
Cell Physiol Biochem. 2015;35(5):2033-42. doi: 10.1159/000374010. Epub 2015 Mar 30.
7
Loss of Androgen-Regulated MicroRNA 1 Activates SRC and Promotes Prostate Cancer Bone Metastasis.雄激素调节的微小RNA 1缺失激活Src并促进前列腺癌骨转移。
Mol Cell Biol. 2015 Jun 1;35(11):1940-51. doi: 10.1128/MCB.00008-15. Epub 2015 Mar 23.
8
MicroRNAs-mediated cell fate in triple negative breast cancers.微小RNA介导的三阴性乳腺癌细胞命运
Cancer Lett. 2015 May 28;361(1):8-12. doi: 10.1016/j.canlet.2015.02.048. Epub 2015 Mar 3.
9
miR-603 promotes glioma cell growth via Wnt/β-catenin pathway by inhibiting WIF1 and CTNNBIP1.miR-603 通过抑制 WIF1 和 CTNNBIP1 促进胶质瘤细胞生长通过 Wnt/β-catenin 通路。
Cancer Lett. 2015 Apr 28;360(1):76-86. doi: 10.1016/j.canlet.2015.02.003. Epub 2015 Feb 10.
10
Role of microRNA 30a targeting insulin receptor substrate 2 in colorectal tumorigenesis.微小RNA 30a靶向胰岛素受体底物2在结直肠癌发生中的作用
Mol Cell Biol. 2015 Mar;35(6):988-1000. doi: 10.1128/MCB.01242-14. Epub 2015 Jan 12.